Pharmaceuticals

Spain Infectious Diseases: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

  • VPG695292
  • 960 Pages
  • September 2016
  • Pharmaceuticals

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Spanish market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
by individual test.

- Volume and sales forecasts for over 100 infectious disease
assays by individual test and market segment:

Hospitals
Blood Banks
Commercial/Private Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
culture/microscopy).

- Review of the market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for infectious disease testing.

- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Contains 960 pages and 153 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Erectile Dysfunction Drugs Market (Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Erectile dysfunction is also termed as impotence and it is characterized by incapability to build up or sustain a penile erection during sexual intercourse. An Erection of penis involves hydraulic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cryosurgery Asia-Pacific Market Research Report, 2013 - 2020

Cryosurgery or Cryotherapy is a minimally invasive treatment that subjects the use of extremely cold temperatures to freeze and destroy diseased tissues, largely used in the treatment of cancer. To ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Pharmaceutical Contract Manufacturing Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Protein Therapeutics Market- Global Share, Analysis, Industry Overview, Growth, Trends Opportunities and Forecast 2012 - 2020

Protein therapeutics is artificially synthesized protein on large scale through genetically modified host cells that is used in treatment of chronic diseases such as cancer, diabetes and CVD. According to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Macular Edema and Macular Degeneration Market (Types, treatment and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market (Types, Drugs and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Acute Lymphocytic/Lymphoblastic leukemia is a kind of blood or bone marrow cancer. It occurs in lymphocytes which are white blood cells. It can then easily spread to the other parts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>